SCHEMBL24933666

SCHEMBL24933666

N#Cc1cccc(COc2ccc(-c3cc(C(N)=O)c(=O)[nH]c3C(F)(F)F)cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.48
FFAR1 O14842 2/20 0.46
FFAR4 Q5NUL3 1/20 0.46
MAOB P27338 6/20 0.44
GRM5 P41594 2/20 0.43
MAOA P21397 2/20 0.43
PDCD1 Q15116 1/20 0.42
CD274 Q9NZQ7 1/20 0.42
ADAMTS4 O75173 1/20 0.41
MMP13 P45452 1/20 0.41
ALOX5 P09917 1/20 0.41
ALOX5AP P20292 1/20 0.41
MRGPRX4 Q96LA9 2/20 0.40
SPHK2 Q9NRA0 1/20 0.40
SPHK1 Q9NYA1 1/20 0.40
CYP19A1 P11511 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
ALKBH1 Q13686 1/20 0.40
PARP10 Q53GL7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24933800 0.90 KCNH2 (0.44) KCNH2FFAR1MAOBMAOAPARP10
SCHEMBL30240782 0.88 MAOB (0.52) MAOBMRGPRX4PARP10
SCHEMBL30240765 0.88 MAOB (0.47) FFAR1FFAR4MAOBMRGPRX4PARP10
SCHEMBL24932976 0.88 MAOB (0.52) MAOBMRGPRX4PARP10
SCHEMBL24933615 0.88 MAOB (0.60) FFAR1FFAR4MAOBMAOAADAMTS4
SCHEMBL24933362 0.88 MAOB (0.47) FFAR1FFAR4MAOBMRGPRX4PARP10
SCHEMBL24933349 0.87 GSTP1 (0.50) FFAR1MAOBPARP10
SCHEMBL24933801 0.87 CD274 (0.44) PDCD1CD274
SCHEMBL24933199 0.86 MAOB (0.46) FFAR1MAOBMAOAMRGPRX4PARP10
SCHEMBL30240807 0.86 MAOB (0.46) FFAR1MAOBMAOAMRGPRX4PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP claimed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN claimed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO claimed
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP disclosed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed